CWHM-12

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCWHM-12
Drug Alias NameCWHM-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V antagonists
TargetsIntegrin alpha-V
Therapy Area/IndicationsPulmonary FibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, San Francisco Foundation
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California, San Francisco Foundation
Inactive CompaniesN/A
Active IndicationsPulmonary FibrosisLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A